Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
<p>Cerebral hypoxia may promote cerebral damage in patients with obstructive sleep apnoea (OSA). We investigated whether OSA patients experience nocturnal cerebral hypoxia that is prevented by continuous positive airway pressure (CPAP).</p> <p>OSA patients using CPAP underwent slee...
Hoofdauteurs: | Schwarz, E, Furian, M, Schlatzer, C, Stradling, J, Kohler, M, Bloch, K |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
European Respiratory Society
2018
|
Gelijkaardige items
-
ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
door: Schlatzer, C, et al.
Gepubliceerd in: (2016) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis.
door: Schwarz, E, et al.
Gepubliceerd in: (2015) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis
door: Schwarz, E, et al.
Gepubliceerd in: (2015) -
Pharmacological approaches to the treatment of obstructive sleep apnoea.
door: Kohler, M, et al.
Gepubliceerd in: (2009) -
The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring.
door: Kohler, M, et al.
Gepubliceerd in: (2007)